Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: A possible event in tumor regression

International Journal of Cancer

Volumn 75, Issue 2, 1998, Pages 284-289

  Saito, Katsunori ^a   Ishikura, Hiroshi ^a   Kishimoto, Takashi ^a   Kawarada, You ^a   Yano, Tomoyuki ^a   Takahashi, Toshiyuki ^a   Kato, Hiroyuki ^a   Yoshiki, Takashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MALE; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; PRIORITY JOURNAL; SCID MOUSE; TUMOR IMMUNOLOGY; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032545722     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980119)75:2<284::AID-IJC18>3.0.CO;2-D     Document Type: Article

References (16)

1. BARNSTABLE, C.J., BODMER, W.F., BROWN, G., GALFRÉ, G., MILSTEIN, C., WILLIAMS, A.F. and ZIEGLER, A., Production of monoclonal antibodies to group A erythrocytes, HLA and other human antigens. New tools for genetic analysis. Cell, 14, 9-18 (1978).
2. DANFOTH, D.N. and SBABIAS, M.K., Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res., 53, 1538-1545 (1993).
3. ENZMANN, H., EDLER, L. and BANNASCH, P., Simple elementary method for the quantification of focal liver lesions induced by carcinogenesis. Carcinogenesis, 8, 231-235 (1987).
4. FOLKMAN, J., Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature (Med.), 1, 27-31 (1995).
5. GITAY-GOREN, H., HALABAN, R. and NEUFELD, G., Human melanoma cells but not normal melanocytes express vascular endothelial growth factor. Biochem. biophys. Res. Comm., 190, 702-709 (1993).
6. a in the adhesion of pancreas carcinoma cells to activated endothelium. Int. J. Cancer, 54, 972-977 (1993).
7. KASAHARA, M. and 13 OTHERS, Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens, Immunology, 53, 79-86 (1984).
8. a antigen. Int. J. Cancer (pred. Oncol.). 69, 290-294 (1996).
9. KOO, A.S., ARMSTRONG, C., BOCHNER, B., SHIMABUKURO, T., TSO, C.L., DE KERNIOU, J.B. and BELLDEGRUN, A., Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer Immunol. Immunother., 35, 97-105 (1992).
10. OHE, Y., PODACK, E.R., OLSEN, K.J., MIYAHARA, Y., MIURA, K., SAITO, Y., KOISHIHARA, Y., OHSUGI, Y., OHIRA, T., KISHIO, K. and SAIJO, N., Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumor growth rate but cause weight loss and shorten survival in syngenic mice. Brit. J. Cancer, 67, 939-944 (1993).
11. OMI, M., ISHIKURA, H., ISHIZU, A., TAKAHASHI, T., KATO, H., and YOSHIKI, T., Interleukin (IL)-6 as a pancreas carcinoma-derived vascular permeability regulator in vitro. Pathol. Res. Pract., 192, 1107-1112 (1996).
12. SUGIURA, H., ISHIKURA, H., OMI, M., KAJI, M., IWAI, K., KISHIMOTO, T., TAKAHASHI, T., KIMURA, C., KATO, H. and YOSHIKI, T., Lymphokineactivated killer cytotoxicity against pancreas-adenocarcinoma cell lines and vascular endothelial cells. Pathol. Int., 44, 688-696 (1994).
13. TAKAHASHI, T., ISHIKURA, H., IWAI, K., TAKAHASHI, C., KATO, H., TANABE, T. and YOSHIKI, T., Cytokine regulation of cell-to-cell interaction in LAK cell cytotoxicity in vitro. Cancer Immunol. Immunother., 36, 76-82 (1993).
14. TSUJISAKI, M., IMAI, K., HIRATA, H., HANZAWA, Y., MASUYA, J., NAKANO, T., SUGIYAMA, T., MATSUI, M., HINODA, Y. and YACHI, A., Detection of circulating intercellular-adhesion-molecule-1 antigen in malignant diseases. Clin. exp. Immunol., 85, 3-8 (1991).
15. WORTIS, H.H., Immunological response of "nude" mice. Clin. exp. Immunol., 8, 305-317 (1971).
16. WU, S., RODABAUGH, K., MARTINEZ-MAZA, O., WATSON, J.M., SILBERSTAIN, D.S., BOYER, C.M., PETERS, W.P., WEINBERG, J.B., BEREK, J.S. and BAST, R.C., Stimulation of ovarian tumor proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α. Amer: J. Obstet. Gynecol., 166, 991-1007 (1992).